catalog number :
MBS427400
products full name :
SETDB2 Immunizing Peptide
products short name :
SETDB2
products name syn :
SETDB2; SET domain; bifurcated 2; C13orf4; CLLD8; CLLL8; DKFZp586I0123; DKFZp761J1217; KMT1F; OTTHUMP00000018418; chronic lymphocytic leukemia deletion region gene 8 protein; histone-lysine N-methyltransfera; Goat Anti-CLLD8 / SETDB2; SETDB2; SET domain,
other names :
histone-lysine N-methyltransferase SETDB2 isoform a; Histone-lysine N-methyltransferase SETDB2; histone-lysine N-methyltransferase SETDB2; lysine N-methyltransferase 1F; chronic lymphocytic leukemia deletion region 8; chronic lymphocytic leukemia deletion region gene 8 protein; SET domain, bifurcated 2; Chronic lymphocytic leukemia deletion region gene 8 protein; Lysine N-methyltransferase 1F; SET domain bifurcated 2
products gene name :
SETDB2
other gene names :
SETDB2; SETDB2; CLLD8; CLLL8; KMT1F; C13orf4; C13orf4; CLLD8; KMT1F
uniprot entry name :
SETB2_HUMAN
reactivity :
Human, Mouse, Dog, Pig, Cow
sequence :
C-QRRHAKTNSHSSALH
form :
100ug of dried peptide
storage stability :
Shipped at ambient temperature, store at -20 degree C
other info1 :
Corresponding Antibody: Catalog #MBS422716
ncbi acc num :
NP_114121.2
ncbi gb acc num :
NM_031915.2
ncbi mol weight :
81,766 Da
ncbi pathways :
Lysine Degradation Pathway 82956!!Lysine Degradation Pathway 320
ncbi summary :
Proteins that contain a SET domain, such as SETDB2, modulate gene expression epigenetically through histone H3 (see MIM 601128) methylation. SETDB2 is likely a histone H3 methyltransferase, as it contains both the active site and flanking cysteine residues required for catalytic activity (Zhang et al., 2003 [PubMed 12754510]).[supplied by OMIM, Mar 2008]